CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

8 hedge funds and large institutions have $3.24M invested in Celyad Oncology SA American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FIG
1
Fortress Investment Group
New York
$3.2M
Citadel Advisors
2
Citadel Advisors
Florida
$14K +$6.18K +13,165 +79%
Morgan Stanley
3
Morgan Stanley
New York
$9.02K -$296 -600 -3%
OMC
4
Old Mission Capital
Illinois
$8.04K +$8.04K +16,319 New
Millennium Management
5
Millennium Management
New York
$5K +$5K +10,993 New
UBS Group
6
UBS Group
Switzerland
$2.84K -$1.43K -2,919 -34%
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$1.67K
Wells Fargo
8
Wells Fargo
California
$281 -$6.06K -12,300 -96%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
-$16K -11,602 Closed
Osaic Holdings
10
Osaic Holdings
Arizona
-$2K -1,500 Closed